📊 Score Breakdown
Offering Ability
70
Cash Runway
0
Float Risk
52
Warrant Exposure
70
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
36%
📜 Warrant Exercise
40%
• Significant warrants: 23% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration
40%
• Score rose 29 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($150M, 88% of market cap)
💹 Market Data
Market Cap$169.66M
Shares Outstanding40.40M
Float17.50M
Cash$192.11M
Debt$409.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 27.5% shares (2025Q4 vs prior)
42 institutional holders · 13.04M shares
#1
ACORN CAPITAL ADVISORS, LLC
2.84M shares
#2
ADAR1 Capital Management, LLC
2.03M shares
#3
CANTOR FITZGERALD, L. P.
1.43M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest199.4K
Days to Cover1.4
% of Float1.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
S-3
SHELF
Apr 24, 2026
3
FORM3
Apr 07, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for OKUR
📊 OKUR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 OKUR Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.